Long-term endoscopic and clinical follow-up of untreated type 1 gastric neuroendocrine tumours

Digestive and Liver Disease

Volumn 39, Issue 6, 2007, Pages 537-543

  Ravizza, D ^a   Fiori, G ^a   Trovato, C ^a   Fazio, N ^a   Bonomo, G ^a   Luca, F ^a   Bodei, L ^a   Pelosi, G ^a   Tamayo, D ^a   Crosta, C ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

Endoscopy; Type 1 gastric neuroendocrine tumour

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; CHROMOGRANIN A; CYANOCOBALAMIN; GASTRIN; HEMOGLOBIN; PARIETAL CELL ANTIBODY; SOMATOSTATIN RECEPTOR;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLOW UP; GASTROSCOPY; HUMAN; MALE; MEDICAL DECISION MAKING; MEDICAL LITERATURE; MEDICAL RECORD; METASTASIS POTENTIAL; NEUROENDOCRINE TUMOR; PATIENT SAFETY; PATIENT SELECTION; STOMACH CANCER; STOMACH SCINTISCANNING; TUMOR VOLUME;

AGED; FEMALE; FOLLOW-UP STUDIES; GASTROSCOPY; HUMANS; MALE; MIDDLE AGED; NEUROENDOCRINE TUMORS; STOMACH NEOPLASMS; TIME FACTORS; TREATMENT REFUSAL;

EID: 34248523524     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2007.01.018     Document Type: Article

References (25)

1. Modlin I.M., Lye K.D., and Kidd M. A 50-year analysis of 562 gastric carcinoids: small tumor or larger problem?. Am J Gastroenterol 99 (2004) 23-32
2. Rindi G., Luinetti O., Cornaggia M., Capella C., and Solcia E. Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathological study. Gastroenterology 104 (1993) 994-1006
3. Bordi C. Gastric carcinoids. Ital J Gastroentrol Hepatol 31 (1999) S94-S97
4. Rindi G., Azzoni C., La Rosa S., Klersy C., Paolotti D., Rappel S., et al. ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis. Gastroenterology 116 (1999) 532-542
5. Rindi G., Bordi C., Rappel S., La Rosa S., Stolte M., and Solcia E. Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior. World J Surg 20 (1996) 168-172
6. Hori K., Fukui H., Imura J., Kojima T., Fujita M., Kawamata H., et al. Benign gastric carcinoid tumor with hypergastrinemia followed up for 12 years. Gastric Cancer 3 (2000) 161-164
7. Ichikawa J., Tanabe S., Koizumi W., Kida Y., Imaizumi H., Kida M., et al. Endoscopic mucosal resection in the management of gastric carcinoids tumors. Endoscopy 35 (2003) 203-206
8. Higashino K., Iishi H., Narahara H., Uedo N., Yano H., Ishiguro S., et al. Endoscopic resection with a two-channel videoendoscope for gastric carcinoid tumors. Hepatogastroenterology 51 (2004) 269-272
9. Hirschowitz B.I., Griffith J., Pellegrin D., and Cummings O.W. Rapid regression of enterochromaffinelike cell gastric carcinoids in pernicious anemia after antrectomy. Gastroenterology 102 (1992) 1409-1418
10. Okada K., Kijima H., Chino O., Matsuyama M., Okamoto Y., Yamamoto S., et al. Multiple gastric carcinoids associated with hypergastrinemia. A review of five cases with clinicopathological analysis and surgical strategies. Anticancer Res 25 (2005) 4417-4422
11. Hosokawa O., Kaizaki Y., Hattori M., Douden K., Hayashi H., Morishita M., et al. Long-term follow up of patients with multiple gastric carcinoids associated with type A gastritis. Gastric Cancer 8 (2005) 42-46
12. Johnson F.E., Smith J.B., Janney C.M., and Ramrakhiani H. Multiple gastric carcinoids. J Am Coll Surg 196 (2003) 984-985
13. Plockinger U., Rindi G., Arnold R., Eriksson B., Krenning E.P., de Herder W.W., et al. Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. Neuroendocrinology 80 (2004) 394-424
14. Prommegger R., Bale R., Ensinger C., Sauper T., Profanter C., Knoflach M., et al. Gastric carcinoid type I tumour: new diagnostic and therapeutic method. Eur J Gastroenterol Hepatol 15 (2003) 705-707
15. Fykse V., Sandvik A.K., Qvigstad G., Falkmer S.E., Syversen U., and Waldum H.L. Treatment of ECL cell carcinoids with octyreotide LAR. Scand J Gastroenterol 39 (2004) 621-628
16. Delle Fave G., Capurso G., Milione M., and Panzuto F. Endocrine tumours of the stomach. Best Pract Res Clin Gastroenterol 19 (2005) 659-673
17. Giordano J. Gastric carcinoid syndrome diagnosed by endoscopy. Am J Gastroenterol 76 (1981) 41-43
18. Marignani M., Delle Fave G., Mecarocci S., Bordi C., Angeletti S., D'Ambra G., et al. High prevalence of atrophic body gastritis in patients with unexplained microcytic and macrocytic anemia: a prospective screening study. Am J Gastroenterol 94 (1999) 766-772
19. Gilligan C.J., Lawton G.P., Tang L.H., West A.B., and Modlin I.M. Gastric carcinoid tumors. The biology and therapy of an enigmatic and controversial lesion. Am J Gastroenterol 90 (1995) 338-352
20. Annibale B., Azzoni C., Corleto V.D., di Giulio E., Caruana P., D'Ambra G., et al. Atrophic body gastritis patients with enterochromaffin-like cell dysplasia are at increased risk for the development of type I gastric carcinoid. Eur J Gastroenterol Hepatol 13 (2001) 1449-1456
21. Baiocchi G.L., Ronconi M., Villanacci V., Gambarotti M., and Giulini S.M. Type 1 gastric carcinoid: is the conservative approach always indicated?. Endoscopy 36 (2004) 457-465
22. Modlin I.M., Lye K.D., and Kidd M. Carcinoid tumors of the stomach. Surg Oncol 12 (2003) 153-172
23. Picus D., Glazer H., Levitt R.G., and Husband J.E. Computed tomography of abdominal carcinoid tumors. Am J Radiol 143 (1984) 581-584
24. Krenning E., Kooij P., Pauwels S., Breeman W.A., Postema P.T., de Herder W.W., et al. Somatostatin receptor scintigraphy and radionuclide therapy. Digestion 57 (1996) 57-61
25. Yoshikane H., Tsukamoto Y., Niwa Y., Goto H., Hase S., Mizutani K., et al. Carcinoid tumors of the gastrointestinal tract: evaluation with endoscopic ultrasonography. Gastrointest Endosc 39 (1993) 375-383